Literature DB >> 15629584

Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?

Mack Roach.   

Abstract

Mesh：

Year:  2005        PMID： 15629584     DOI： 10.1016/j.ijrobp.2004.05.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  5 in total

Review 1.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

2.  Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.

Authors:  Neelam Tyagi; Sandra Fontenla; Jing Zhang; Michelle Cloutier; Mo Kadbi; Jim Mechalakos; Michael Zelefsky; Joe Deasy; Margie Hunt
Journal:  Phys Med Biol       Date:  2016-12-16       Impact factor: 3.609

3.  Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.

Authors:  F Böckelmann; M Hammon; S Lettmaier; R Fietkau; C Bert; F Putz
Journal:  Strahlenther Onkol       Date:  2018-10-12       Impact factor: 3.621

4.  Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning.

Authors:  Lucia Perna; Cesare Cozzarini; Eleonora Maggiulli; Gianni Fellin; Tiziana Rancati; Riccardo Valdagni; Vittorio Vavassori; Sergio Villa; Claudio Fiorino
Journal:  Radiat Oncol       Date:  2011-09-24       Impact factor: 3.481

5.  Clinical workflow for MR-only simulation and planning in prostate.

Authors:  Neelam Tyagi; Sandra Fontenla; Michael Zelefsky; Marcia Chong-Ton; Kyle Ostergren; Niral Shah; Lizette Warner; Mo Kadbi; Jim Mechalakos; Margie Hunt
Journal:  Radiat Oncol       Date:  2017-07-17       Impact factor: 3.481
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.